Press release
Investigation announced for Investors in EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) over possible Violations of Securities Laws
An investigation for investors in EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) shares.
Investors who purchased shares of EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on whether a series of statements by EyePoint Pharmaceuticals, Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.
Watertown, MA based EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom.
On August 30, 2022, after market hours, EyePoint Pharmaceuticals, Inc. disclosed that it had received a subpoena from the U.S. Attorney's Office for the District of Massachusetts seeking documents regarding sales practices for its postoperative inflammation treatment, DEXYCU.
Shares of EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) declined from $11.44 per share on August 12, 2022, to as low as $5.31 per share on October 12, 2022.
Those who purchased shares of EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) have certain options and should contact the Shareholders Foundation.
Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Investigation announced for Investors in EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) over possible Violations of Securities Laws here
News-ID: 2776492 • Views: …
More Releases from Shareholders Foundation
ALERT: Lawsuit filed for Investors who SOLD shares of Sina Corporation (formerly …
An investor, who sold shares of Sina Corporation (formerly NASDAQ: SINA) in the merger between Seina Corporation and TuSimple Holdings, Inc, filed a lawsuit over alleged violations of Federal Securities Laws by Sina Corporation (formerly NASDAQ: SINA in connection with certain allegedly false and misleading statements made.
If you sold a significant amount of shares of Sina Corporation (formerly NASDAQ: SINA) between October 13, 2020 and March 22, 2021, you have…
Lawsuit Alert: Investors who lost money with shares of Fluor Corporation (NYSE: …
An investor, who purchased shares of Fluor Corporation (NYSE: FLR), filed a lawsuit alleged violations of Federal Securities Laws by Fluor Corporation in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Fluor Corporation (NYSE: FLR) have certain options and for certain investors are short and strict deadlines running. Deadline: November 14, 2025. NYSE: FLR investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779…
Investigation announced for Long-Term Investors in shares of Sable Offshore Corp …
An investigation was announced for long-term investors in shares of Sable Offshore Corp. (NYSE: SOC) concerning potential breaches of fiduciary duties by certain directors of Sable Offshore Corp.
Investors who are current long term investors in Sable Offshore Corp. (NYSE: SOC) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in…
Lawsuit filed for Investors who lost money with shares of Lantheus Holdings, Inc …
An investor, who purchased shares of Lantheus Holdings, Inc. (NASDAQ: LNTH), filed a lawsuit over alleged violations of Federal Securities Laws by Lantheus Holdings, Inc. in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Lantheus Holdings, Inc. (NASDAQ: LNTH) have certain options and for certain investors are short and strict deadlines running. Deadline: November 10, 2025. NASDAQ: LNTH investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com…
More Releases for EyePoint
Pars Planitis Market Set to Grow Substantially Through 2032, DelveInsight Projec …
DelveInsight's "Pars Planitis Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Pars Planitis, historical and forecasted epidemiology as well as the Pars Planitis market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Pars Planitis market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Pars Planitis Market Forecast
https://www.delveinsight.com/sample-request/pars-plantis-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Some of the…
Nano Silicon Drug Delivery Platform Market to Witness Massive Growth by 2032 | S …
Latest Qualitative Research Report on the Nano Silicon Drug Delivery Platform Market 2025, published by Coherent Market Insights, provides valuable insights into both regional and global markets projected to grow in value from 2025 to 2032. The comprehensive research explores into the evolving Market's dynamics, value chain analysis, prominent investment areas, competitive landscape, drivers and constraints, regional outlook, and key market segments. It's also provides the industry overview with growth…
Wet Age-Related Macular Degeneration Pipeline 2024 | OliX Pharmaceuticals, Front …
DelveInsight's, "Wet Age-Related Macular Degeneration (Wet-AMD) Pipeline Insight, 2024," report provides comprehensive insights about 70+ companies and 75+ pipeline drugs in Wet Age-Related Macular Degeneration (Wet-AMD) pipeline landscape. It covers the Wet Age-Related Macular Degeneration pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Wet Age-Related Macular Degeneration therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline…
Intravitreal Injectable Market Size Will Observe Lucrative Surge by the End 2030 …
Intravitreal Injectable Market research report forecast 2023-2030 has been prepared by experienced and knowledgeable market analysts and researchers. Each section of the research study is specially prepared to explore key aspects of the Industry. Buyers of the report will have access to accurate Porter's 5 Analysis, PESTLE, SWOT, and other types of analysis on the global Intravitreal Injectable market. The report aims to provide a thorough and accurate analysis of…
Uveitis Treatment Market 2023 Global Size, Share, & Industry Growth Analysis by …
Uveitis Treatment Market Growth Overview
The Uveitis Treatment market research report provides information on the size of the global market overall, market share values, recent market developments and potential business opportunities, sales and competitive landscape analysis, upcoming product launches, technological innovations, revenue and trade regulation analysis, among other things. The main players on the global market are also examined in the study, with company biographies, SWOT analysis, and recent developments provided.
Get…
Stye Drug Market – Pfizer Inc, XOMA, EyePoint Pharmaceuticals, Enzo Biochem In …
A superior and comprehensive market research report endows professionals with a lot of aspects about the market and the industry. The Stye Drug report presents market potential for each geographical region based on the growth rate, macroeconomic parameters, consumer buying patterns, their preferences for particular product and market demand and supply scenarios. Market segmentation analyses the usage of the product with respect to its applications, end user or with respect…
